Changed patent policy and biopharma innovation in India by foreign investment and technology transfer

Presented at GLOBELICS 2009, 7th International Conference, 6-8 October, Dakar, Senegal.Parallel session 5: Globalisation, IP and innovation in biotech and pharmaceuticalsThe paper has measured the relationship between the intellectual property rights and Foreign Direct Investment in the context of Indian biopharma Industry in order to know the impact of TRIPs agreement of WTO on the biopharmaceutical industry of developing countries. The central issue in this study is the extent to which patent reform (after the imposition of the TRIPs agreement in 1995) affects India’s ability to attract technology transfer for the biopharmaceutical drugs innovation. For the same this study has done an analysis of FDI flow in biopharma industry in Pre TRIPs (before the imposition of product patent protection 1991-1999) and post TRIPs (after the product patent protection, 1999-2005) along with a comparative analysis of the relationship between the amount of foreign investment flown in different Indian states and the investment climate ranking of those states which are the part of Indian biocluster